N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide

C128H173BrN28O14S3 — CID 158495444

IUPACN-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide
SMILESC.C.C.C.C.CC(=O)Nc1ccc(C)c(Br)c1C(=O)N1CCCC[C@H]1c1cc2nc(C)c(C)c(C)n2n1.CC(=O)Nc1ccc(C)cc1C(=O)N1CCCC[C@H]1c1cc2nc(C)c(C)c(C)n2n1.CCc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(N4CCC4)cc(N4CCOCC4)n3n2)c1.Cc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(C)c(C)c(N4CCC4)n3n2)c1.Cc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(C)c(C)cn3n2)c1
InChIInChI=1S/C28H37N7O4S.C25H32N6O3S.C24H28BrN5O2.C24H29N5O2.C22H27N5O3S.5CH4/c1-3-20-8-9-22(31-40(2,37)38)21(17-20)28(36)34-12-5-4-7-24(34)23-18-26-29-25(32-10-6-11-32)19-27(35(26)30-23)33-13-15-39-16-14-33;1-16-9-10-20(28-35(4,33)34)19(14-16)25(32)30-13-6-5-8-22(30)21-15-23-26-18(3)17(2)24(31(23)27-21)29-11-7-12-29;1-13-9-10-18(27-17(5)31)22(23(13)25)24(32)29-11-7-6-8-20(29)19-12-21-26-15(3)14(2)16(4)30(21)28-19;1-14-9-10-20(26-18(5)30)19(12-14)24(31)28-11-7-6-8-22(28)21-13-23-25-16(3)15(2)17(4)29(23)27-21;1-14-8-9-18(25-31(4,29)30)17(11-14)22(28)26-10-6-5-7-20(26)19-12-21-23-16(3)15(2)13-27(21)24-19;;;;;/h8-9,17-19,24,31H,3-7,10-16H2,1-2H3;9-10,14-15,22,28H,5-8,11-13H2,1-4H3;9-10,12,20H,6-8,11H2,1-5H3,(H,27,31);9-10,12-13,22H,6-8,11H2,1-5H3,(H,26,30);8-9,11-13,20,25H,5-7,10H2,1-4H3;5*1H4/t24-;22-;20-;22-;20-;;;;;/m00000...../s1
InChIKeyHJFOFRXIMNPMPM-QCLABKFKSA-N
MW2504.08 g/mol
LogP22.59
Rot. Bonds22

About N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide

N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide (PubChem CID 158495444) has the molecular formula C128H173BrN28O14S3 and a molecular weight of 2504.08 g/mol. Its IUPAC name is N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide.

Molecular Properties

Compound NameN-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide
PubChem CID158495444
Molecular FormulaC128H173BrN28O14S3
Molecular Weight2504.08 g/mol
Exact Mass2501.20
IUPAC NameN-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide
SMILESC.C.C.C.C.CC(=O)Nc1ccc(C)c(Br)c1C(=O)N1CCCC[C@H]1c1cc2nc(C)c(C)c(C)n2n1.CC(=O)Nc1ccc(C)cc1C(=O)N1CCCC[C@H]1c1cc2nc(C)c(C)c(C)n2n1.CCc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(N4CCC4)cc(N4CCOCC4)n3n2)c1.Cc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(C)c(C)c(N4CCC4)n3n2)c1.Cc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(C)c(C)cn3n2)c1
InChIInChI=1S/C28H37N7O4S.C25H32N6O3S.C24H28BrN5O2.C24H29N5O2.C22H27N5O3S.5CH4/c1-3-20-8-9-22(31-40(2,37)38)21(17-20)28(36)34-12-5-4-7-24(34)23-18-26-29-25(32-10-6-11-32)19-27(35(26)30-23)33-13-15-39-16-14-33;1-16-9-10-20(28-35(4,33)34)19(14-16)25(32)30-13-6-5-8-22(30)21-15-23-26-18(3)17(2)24(31(23)27-21)29-11-7-12-29;1-13-9-10-18(27-17(5)31)22(23(13)25)24(32)29-11-7-6-8-20(29)19-12-21-26-15(3)14(2)16(4)30(21)28-19;1-14-9-10-20(26-18(5)30)19(12-14)24(31)28-11-7-6-8-22(28)21-13-23-25-16(3)15(2)17(4)29(23)27-21;1-14-8-9-18(25-31(4,29)30)17(11-14)22(28)26-10-6-5-7-20(26)19-12-21-23-16(3)15(2)13-27(21)24-19;;;;;/h8-9,17-19,24,31H,3-7,10-16H2,1-2H3;9-10,14-15,22,28H,5-8,11-13H2,1-4H3;9-10,12,20H,6-8,11H2,1-5H3,(H,27,31);9-10,12-13,22H,6-8,11H2,1-5H3,(H,26,30);8-9,11-13,20,25H,5-7,10H2,1-4H3;5*1H4/t24-;22-;20-;22-;20-;;;;;/m00000...../s1
InChIKeyHJFOFRXIMNPMPM-QCLABKFKSA-N
XLogP22.59
TPSA468.16 Ų
H-Bond Donors5
H-Bond Acceptors32
Rotatable Bonds22
Heavy Atoms174
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002504.08
LogP ≤ 522.59
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1032

Analyze N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide?
The IUPAC name of N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide (CID 158495444) is N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide.
What is the SMILES notation for N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide?
The canonical SMILES for N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide is C.C.C.C.C.CC(=O)Nc1ccc(C)c(Br)c1C(=O)N1CCCC[C@H]1c1cc2nc(C)c(C)c(C)n2n1.CC(=O)Nc1ccc(C)cc1C(=O)N1CCCC[C@H]1c1cc2nc(C)c(C)c(C)n2n1.CCc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(N4CCC4)cc(N4CCOCC4)n3n2)c1.Cc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(C)c(C)c(N4CCC4)n3n2)c1.Cc1ccc(NS(C)(=O)=O)c(C(=O)N2CCCC[C@H]2c2cc3nc(C)c(C)cn3n2)c1.
What is the InChIKey of N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide?
The InChIKey is HJFOFRXIMNPMPM-QCLABKFKSA-N. The full InChI is InChI=1S/C28H37N7O4S.C25H32N6O3S.C24H28BrN5O2.C24H29N5O2.C22H27N5O3S.5CH4/c1-3-20-8-9-22(31-40(2,37)38)21(17-20)28(36)34-12-5-4-7-24(34)23-18-26-29-25(32-10-6-11-32)19-27(35(26)30-23)33-13-15-39-16-14-33;1-16-9-10-20(28-35(4,33)34)19(14-16)25(32)30-13-6-5-8-22(30)21-15-23-26-18(3)17(2)24(31(23)27-21)29-11-7-12-29;1-13-9-10-18(27-17(5)31)22(23(13)25)24(32)29-11-7-6-8-20(29)19-12-21-26-15(3)14(2)16(4)30(21)28-19;1-14-9-10-20(26-18(5)30)19(12-14)24(31)28-11-7-6-8-22(28)21-13-23-25-16(3)15(2)17(4)29(23)27-21;1-14-8-9-18(25-31(4,29)30)17(11-14)22(28)26-10-6-5-7-20(26)19-12-21-23-16(3)15(2)13-27(21)24-19;;;;;/h8-9,17-19,24,31H,3-7,10-16H2,1-2H3;9-10,14-15,22,28H,5-8,11-13H2,1-4H3;9-10,12,20H,6-8,11H2,1-5H3,(H,27,31);9-10,12-13,22H,6-8,11H2,1-5H3,(H,26,30);8-9,11-13,20,25H,5-7,10H2,1-4H3;5*1H4/t24-;22-;20-;22-;20-;;;;;/m00000...../s1.
What are the key properties of N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide?
N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide has a molecular weight of 2504.08 g/mol, XLogP of 22.59, 22 rotatable bonds, 5 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(2S)-2-[7-(azetidin-1-yl)-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;N-[2-[(2S)-2-[5-(azetidin-1-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-ethylphenyl]methanesulfonamide;N-[3-bromo-4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide;N-[2-[(2S)-2-(5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]-4-methylphenyl]methanesulfonamide;methane;N-[4-methyl-2-[(2S)-2-(5,6,7-trimethylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]acetamide is sourced from PubChem (CID 158495444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).